Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Viking Therapeutics initiates VOYAGE study for VK2809 in NASH Viking Therapeutics has initiated the VOYAGE study, a phase 2b clinical trial of its liver-selective thyroid hormone receptor… bypharmanewsdailyNovember 20, 2019